nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—ABCG2—Teniposide—lymphatic system cancer	0.154	0.222	CbGbCtD
Venlafaxine—ABCG2—Mitoxantrone—lymphatic system cancer	0.108	0.155	CbGbCtD
Venlafaxine—ABCG2—Vincristine—lymphatic system cancer	0.074	0.107	CbGbCtD
Venlafaxine—CYP2C19—Teniposide—lymphatic system cancer	0.0688	0.0991	CbGbCtD
Venlafaxine—CYP2C9—Teniposide—lymphatic system cancer	0.0572	0.0824	CbGbCtD
Venlafaxine—ABCG2—Methotrexate—lymphatic system cancer	0.0448	0.0646	CbGbCtD
Venlafaxine—ABCB1—Mitoxantrone—lymphatic system cancer	0.0388	0.0559	CbGbCtD
Venlafaxine—CYP3A4—Cytarabine—lymphatic system cancer	0.0337	0.0486	CbGbCtD
Venlafaxine—CYP3A4—Teniposide—lymphatic system cancer	0.0332	0.0479	CbGbCtD
Venlafaxine—ABCB1—Vincristine—lymphatic system cancer	0.0267	0.0385	CbGbCtD
Venlafaxine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0232	0.0335	CbGbCtD
Venlafaxine—ABCB1—Methotrexate—lymphatic system cancer	0.0162	0.0233	CbGbCtD
Venlafaxine—CYP3A4—Vincristine—lymphatic system cancer	0.016	0.023	CbGbCtD
Venlafaxine—Mouth ulceration—Methotrexate—lymphatic system cancer	0.000267	0.000874	CcSEcCtD
Venlafaxine—Urine output increased—Methotrexate—lymphatic system cancer	0.000267	0.000874	CcSEcCtD
Venlafaxine—Ecchymosis—Methotrexate—lymphatic system cancer	0.000267	0.000874	CcSEcCtD
Venlafaxine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000266	0.000871	CcSEcCtD
Venlafaxine—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000265	0.000865	CcSEcCtD
Venlafaxine—Alopecia—Mitoxantrone—lymphatic system cancer	0.000263	0.000861	CcSEcCtD
Venlafaxine—Confusional state—Bleomycin—lymphatic system cancer	0.000263	0.00086	CcSEcCtD
Venlafaxine—Vision blurred—Carmustine—lymphatic system cancer	0.000263	0.00086	CcSEcCtD
Venlafaxine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000262	0.000858	CcSEcCtD
Venlafaxine—Tremor—Carmustine—lymphatic system cancer	0.000262	0.000855	CcSEcCtD
Venlafaxine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000261	0.000853	CcSEcCtD
Venlafaxine—Oedema—Bleomycin—lymphatic system cancer	0.000261	0.000853	CcSEcCtD
Venlafaxine—Erythema—Mitoxantrone—lymphatic system cancer	0.00026	0.000849	CcSEcCtD
Venlafaxine—Infection—Bleomycin—lymphatic system cancer	0.000259	0.000848	CcSEcCtD
Venlafaxine—Anaemia—Carmustine—lymphatic system cancer	0.000258	0.000844	CcSEcCtD
Venlafaxine—Back pain—Vincristine—lymphatic system cancer	0.000258	0.000843	CcSEcCtD
Venlafaxine—Vomiting—Teniposide—lymphatic system cancer	0.000258	0.000842	CcSEcCtD
Venlafaxine—Agitation—Carmustine—lymphatic system cancer	0.000257	0.000839	CcSEcCtD
Venlafaxine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000256	0.000836	CcSEcCtD
Venlafaxine—Asthenia—Fludarabine—lymphatic system cancer	0.000255	0.000835	CcSEcCtD
Venlafaxine—Rash—Teniposide—lymphatic system cancer	0.000255	0.000835	CcSEcCtD
Venlafaxine—Dermatitis—Teniposide—lymphatic system cancer	0.000255	0.000834	CcSEcCtD
Venlafaxine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000254	0.000831	CcSEcCtD
Venlafaxine—Headache—Teniposide—lymphatic system cancer	0.000254	0.00083	CcSEcCtD
Venlafaxine—Pruritus—Fludarabine—lymphatic system cancer	0.000252	0.000823	CcSEcCtD
Venlafaxine—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000252	0.000823	CcSEcCtD
Venlafaxine—Back pain—Mitoxantrone—lymphatic system cancer	0.000251	0.000821	CcSEcCtD
Venlafaxine—Leukopenia—Carmustine—lymphatic system cancer	0.00025	0.000817	CcSEcCtD
Venlafaxine—Anorexia—Bleomycin—lymphatic system cancer	0.000249	0.000813	CcSEcCtD
Venlafaxine—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000248	0.000811	CcSEcCtD
Venlafaxine—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000247	0.000807	CcSEcCtD
Venlafaxine—Anaemia—Vincristine—lymphatic system cancer	0.000246	0.000805	CcSEcCtD
Venlafaxine—Agitation—Vincristine—lymphatic system cancer	0.000245	0.000801	CcSEcCtD
Venlafaxine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000245	0.0008	CcSEcCtD
Venlafaxine—Polyuria—Methotrexate—lymphatic system cancer	0.000245	0.0008	CcSEcCtD
Venlafaxine—Hypotension—Bleomycin—lymphatic system cancer	0.000244	0.000797	CcSEcCtD
Venlafaxine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000244	0.000796	CcSEcCtD
Venlafaxine—Convulsion—Carmustine—lymphatic system cancer	0.000242	0.000791	CcSEcCtD
Venlafaxine—Hypertension—Carmustine—lymphatic system cancer	0.000241	0.000788	CcSEcCtD
Venlafaxine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000241	0.000787	CcSEcCtD
Venlafaxine—Nausea—Teniposide—lymphatic system cancer	0.000241	0.000787	CcSEcCtD
Venlafaxine—Anaemia—Mitoxantrone—lymphatic system cancer	0.00024	0.000784	CcSEcCtD
Venlafaxine—Vertigo—Vincristine—lymphatic system cancer	0.000239	0.000783	CcSEcCtD
Venlafaxine—Leukopenia—Vincristine—lymphatic system cancer	0.000239	0.00078	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000238	0.000778	CcSEcCtD
Venlafaxine—Chest pain—Carmustine—lymphatic system cancer	0.000238	0.000777	CcSEcCtD
Venlafaxine—Myalgia—Carmustine—lymphatic system cancer	0.000238	0.000777	CcSEcCtD
Venlafaxine—Anxiety—Carmustine—lymphatic system cancer	0.000237	0.000774	CcSEcCtD
Venlafaxine—Paraesthesia—Bleomycin—lymphatic system cancer	0.000234	0.000766	CcSEcCtD
Venlafaxine—Malaise—Mitoxantrone—lymphatic system cancer	0.000234	0.000765	CcSEcCtD
Venlafaxine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000233	0.000761	CcSEcCtD
Venlafaxine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000232	0.00076	CcSEcCtD
Venlafaxine—Convulsion—Vincristine—lymphatic system cancer	0.000231	0.000755	CcSEcCtD
Venlafaxine—Hypertension—Vincristine—lymphatic system cancer	0.00023	0.000752	CcSEcCtD
Venlafaxine—Confusional state—Carmustine—lymphatic system cancer	0.00023	0.000751	CcSEcCtD
Venlafaxine—Oedema—Carmustine—lymphatic system cancer	0.000228	0.000745	CcSEcCtD
Venlafaxine—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000228	0.000744	CcSEcCtD
Venlafaxine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000227	0.000742	CcSEcCtD
Venlafaxine—Myalgia—Vincristine—lymphatic system cancer	0.000227	0.000742	CcSEcCtD
Venlafaxine—Visual disturbance—Methotrexate—lymphatic system cancer	0.000227	0.000741	CcSEcCtD
Venlafaxine—Cough—Mitoxantrone—lymphatic system cancer	0.000227	0.00074	CcSEcCtD
Venlafaxine—Infection—Carmustine—lymphatic system cancer	0.000226	0.00074	CcSEcCtD
Venlafaxine—Vomiting—Fludarabine—lymphatic system cancer	0.000226	0.00074	CcSEcCtD
Venlafaxine—Convulsion—Mitoxantrone—lymphatic system cancer	0.000225	0.000735	CcSEcCtD
Venlafaxine—Rash—Fludarabine—lymphatic system cancer	0.000224	0.000734	CcSEcCtD
Venlafaxine—Dermatitis—Fludarabine—lymphatic system cancer	0.000224	0.000733	CcSEcCtD
Venlafaxine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000224	0.000733	CcSEcCtD
Venlafaxine—Pain—Bleomycin—lymphatic system cancer	0.000223	0.00073	CcSEcCtD
Venlafaxine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000223	0.000729	CcSEcCtD
Venlafaxine—Headache—Fludarabine—lymphatic system cancer	0.000223	0.000729	CcSEcCtD
Venlafaxine—Tachycardia—Carmustine—lymphatic system cancer	0.000222	0.000727	CcSEcCtD
Venlafaxine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000221	0.000722	CcSEcCtD
Venlafaxine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000221	0.000722	CcSEcCtD
Venlafaxine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000221	0.000722	CcSEcCtD
Venlafaxine—Anxiety—Mitoxantrone—lymphatic system cancer	0.00022	0.00072	CcSEcCtD
Venlafaxine—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000219	0.000716	CcSEcCtD
Venlafaxine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000218	0.000714	CcSEcCtD
Venlafaxine—Oedema—Vincristine—lymphatic system cancer	0.000218	0.000711	CcSEcCtD
Venlafaxine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000218	0.000711	CcSEcCtD
Venlafaxine—Anorexia—Carmustine—lymphatic system cancer	0.000217	0.00071	CcSEcCtD
Venlafaxine—Infection—Vincristine—lymphatic system cancer	0.000216	0.000706	CcSEcCtD
Venlafaxine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000215	0.000703	CcSEcCtD
Venlafaxine—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000215	0.000702	CcSEcCtD
Venlafaxine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000214	0.000698	CcSEcCtD
Venlafaxine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000213	0.000696	CcSEcCtD
Venlafaxine—Hypotension—Carmustine—lymphatic system cancer	0.000213	0.000696	CcSEcCtD
Venlafaxine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000212	0.000693	CcSEcCtD
Venlafaxine—Oedema—Mitoxantrone—lymphatic system cancer	0.000212	0.000693	CcSEcCtD
Venlafaxine—Nausea—Fludarabine—lymphatic system cancer	0.000211	0.000691	CcSEcCtD
Venlafaxine—Infection—Mitoxantrone—lymphatic system cancer	0.00021	0.000688	CcSEcCtD
Venlafaxine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00021	0.000687	CcSEcCtD
Venlafaxine—Shock—Mitoxantrone—lymphatic system cancer	0.000208	0.000681	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000208	0.000679	CcSEcCtD
Venlafaxine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000207	0.000678	CcSEcCtD
Venlafaxine—Urticaria—Bleomycin—lymphatic system cancer	0.000207	0.000678	CcSEcCtD
Venlafaxine—Anorexia—Vincristine—lymphatic system cancer	0.000207	0.000678	CcSEcCtD
Venlafaxine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000207	0.000676	CcSEcCtD
Venlafaxine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000206	0.000675	CcSEcCtD
Venlafaxine—Insomnia—Carmustine—lymphatic system cancer	0.000206	0.000674	CcSEcCtD
Venlafaxine—Irritability—Methotrexate—lymphatic system cancer	0.000205	0.00067	CcSEcCtD
Venlafaxine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000205	0.000669	CcSEcCtD
Venlafaxine—Paraesthesia—Carmustine—lymphatic system cancer	0.000205	0.000669	CcSEcCtD
Venlafaxine—Mood swings—Methotrexate—lymphatic system cancer	0.000203	0.000665	CcSEcCtD
Venlafaxine—Hypotension—Vincristine—lymphatic system cancer	0.000203	0.000664	CcSEcCtD
Venlafaxine—Dyspnoea—Carmustine—lymphatic system cancer	0.000203	0.000664	CcSEcCtD
Venlafaxine—Somnolence—Carmustine—lymphatic system cancer	0.000203	0.000662	CcSEcCtD
Venlafaxine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000202	0.00066	CcSEcCtD
Venlafaxine—Ataxia—Methotrexate—lymphatic system cancer	0.000202	0.00066	CcSEcCtD
Venlafaxine—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000198	0.000648	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000198	0.000648	CcSEcCtD
Venlafaxine—Decreased appetite—Carmustine—lymphatic system cancer	0.000198	0.000648	CcSEcCtD
Venlafaxine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000198	0.000647	CcSEcCtD
Venlafaxine—Insomnia—Vincristine—lymphatic system cancer	0.000197	0.000643	CcSEcCtD
Venlafaxine—Paraesthesia—Vincristine—lymphatic system cancer	0.000195	0.000639	CcSEcCtD
Venlafaxine—Constipation—Carmustine—lymphatic system cancer	0.000195	0.000637	CcSEcCtD
Venlafaxine—Pain—Carmustine—lymphatic system cancer	0.000195	0.000637	CcSEcCtD
Venlafaxine—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000193	0.000632	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000193	0.000631	CcSEcCtD
Venlafaxine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000192	0.000629	CcSEcCtD
Venlafaxine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00019	0.000622	CcSEcCtD
Venlafaxine—Decreased appetite—Vincristine—lymphatic system cancer	0.000189	0.000618	CcSEcCtD
Venlafaxine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000189	0.000617	CcSEcCtD
Venlafaxine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000188	0.000616	CcSEcCtD
Venlafaxine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000188	0.000614	CcSEcCtD
Venlafaxine—Fatigue—Vincristine—lymphatic system cancer	0.000188	0.000613	CcSEcCtD
Venlafaxine—Asthenia—Bleomycin—lymphatic system cancer	0.000187	0.000612	CcSEcCtD
Venlafaxine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000186	0.00061	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000186	0.000609	CcSEcCtD
Venlafaxine—Constipation—Vincristine—lymphatic system cancer	0.000186	0.000608	CcSEcCtD
Venlafaxine—Pain—Vincristine—lymphatic system cancer	0.000186	0.000608	CcSEcCtD
Venlafaxine—Asthma—Methotrexate—lymphatic system cancer	0.000186	0.000607	CcSEcCtD
Venlafaxine—Pruritus—Bleomycin—lymphatic system cancer	0.000185	0.000604	CcSEcCtD
Venlafaxine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000184	0.000602	CcSEcCtD
Venlafaxine—Eosinophilia—Methotrexate—lymphatic system cancer	0.000184	0.000601	CcSEcCtD
Venlafaxine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000183	0.000597	CcSEcCtD
Venlafaxine—Pancreatitis—Methotrexate—lymphatic system cancer	0.000182	0.000595	CcSEcCtD
Venlafaxine—Pain—Mitoxantrone—lymphatic system cancer	0.000181	0.000592	CcSEcCtD
Venlafaxine—Constipation—Mitoxantrone—lymphatic system cancer	0.000181	0.000592	CcSEcCtD
Venlafaxine—Abdominal pain—Carmustine—lymphatic system cancer	0.00018	0.000589	CcSEcCtD
Venlafaxine—Body temperature increased—Carmustine—lymphatic system cancer	0.00018	0.000589	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000178	0.000581	CcSEcCtD
Venlafaxine—Pancytopenia—Methotrexate—lymphatic system cancer	0.000176	0.000576	CcSEcCtD
Venlafaxine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000175	0.000571	CcSEcCtD
Venlafaxine—Dysuria—Methotrexate—lymphatic system cancer	0.000174	0.000567	CcSEcCtD
Venlafaxine—Neutropenia—Methotrexate—lymphatic system cancer	0.000174	0.000567	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000173	0.000566	CcSEcCtD
Venlafaxine—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000173	0.000564	CcSEcCtD
Venlafaxine—Abdominal pain—Vincristine—lymphatic system cancer	0.000172	0.000562	CcSEcCtD
Venlafaxine—Body temperature increased—Vincristine—lymphatic system cancer	0.000172	0.000562	CcSEcCtD
Venlafaxine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000171	0.000559	CcSEcCtD
Venlafaxine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000169	0.000554	CcSEcCtD
Venlafaxine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000168	0.00055	CcSEcCtD
Venlafaxine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000168	0.000549	CcSEcCtD
Venlafaxine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000167	0.000547	CcSEcCtD
Venlafaxine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000167	0.000547	CcSEcCtD
Venlafaxine—Pneumonia—Methotrexate—lymphatic system cancer	0.000166	0.000544	CcSEcCtD
Venlafaxine—Vomiting—Bleomycin—lymphatic system cancer	0.000166	0.000543	CcSEcCtD
Venlafaxine—Depression—Methotrexate—lymphatic system cancer	0.000165	0.000539	CcSEcCtD
Venlafaxine—Rash—Bleomycin—lymphatic system cancer	0.000165	0.000538	CcSEcCtD
Venlafaxine—Dermatitis—Bleomycin—lymphatic system cancer	0.000164	0.000538	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000164	0.000536	CcSEcCtD
Venlafaxine—Asthenia—Carmustine—lymphatic system cancer	0.000163	0.000534	CcSEcCtD
Venlafaxine—Renal failure—Methotrexate—lymphatic system cancer	0.000163	0.000532	CcSEcCtD
Venlafaxine—Stomatitis—Methotrexate—lymphatic system cancer	0.000161	0.000527	CcSEcCtD
Venlafaxine—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000161	0.000526	CcSEcCtD
Venlafaxine—Hypersensitivity—Vincristine—lymphatic system cancer	0.00016	0.000524	CcSEcCtD
Venlafaxine—Sweating—Methotrexate—lymphatic system cancer	0.000159	0.000519	CcSEcCtD
Venlafaxine—Haematuria—Methotrexate—lymphatic system cancer	0.000158	0.000516	CcSEcCtD
Venlafaxine—Epistaxis—Methotrexate—lymphatic system cancer	0.000156	0.00051	CcSEcCtD
Venlafaxine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000156	0.00051	CcSEcCtD
Venlafaxine—Asthenia—Vincristine—lymphatic system cancer	0.000156	0.00051	CcSEcCtD
Venlafaxine—Diarrhoea—Carmustine—lymphatic system cancer	0.000156	0.00051	CcSEcCtD
Venlafaxine—Nausea—Bleomycin—lymphatic system cancer	0.000155	0.000507	CcSEcCtD
Venlafaxine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000154	0.000505	CcSEcCtD
Venlafaxine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000152	0.000497	CcSEcCtD
Venlafaxine—Dizziness—Carmustine—lymphatic system cancer	0.000151	0.000493	CcSEcCtD
Venlafaxine—Haemoglobin—Methotrexate—lymphatic system cancer	0.000149	0.000488	CcSEcCtD
Venlafaxine—Diarrhoea—Vincristine—lymphatic system cancer	0.000149	0.000487	CcSEcCtD
Venlafaxine—Haemorrhage—Methotrexate—lymphatic system cancer	0.000149	0.000486	CcSEcCtD
Venlafaxine—Hepatitis—Methotrexate—lymphatic system cancer	0.000149	0.000486	CcSEcCtD
Venlafaxine—Pharyngitis—Methotrexate—lymphatic system cancer	0.000147	0.000482	CcSEcCtD
Venlafaxine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000145	0.000474	CcSEcCtD
Venlafaxine—Vomiting—Carmustine—lymphatic system cancer	0.000145	0.000474	CcSEcCtD
Venlafaxine—Dizziness—Vincristine—lymphatic system cancer	0.000144	0.00047	CcSEcCtD
Venlafaxine—Rash—Carmustine—lymphatic system cancer	0.000144	0.00047	CcSEcCtD
Venlafaxine—Dermatitis—Carmustine—lymphatic system cancer	0.000144	0.000469	CcSEcCtD
Venlafaxine—Visual impairment—Methotrexate—lymphatic system cancer	0.000143	0.000468	CcSEcCtD
Venlafaxine—Headache—Carmustine—lymphatic system cancer	0.000143	0.000467	CcSEcCtD
Venlafaxine—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00014	0.000459	CcSEcCtD
Venlafaxine—Tinnitus—Methotrexate—lymphatic system cancer	0.000139	0.000453	CcSEcCtD
Venlafaxine—Vomiting—Vincristine—lymphatic system cancer	0.000138	0.000452	CcSEcCtD
Venlafaxine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000138	0.000451	CcSEcCtD
Venlafaxine—Rash—Vincristine—lymphatic system cancer	0.000137	0.000448	CcSEcCtD
Venlafaxine—Dermatitis—Vincristine—lymphatic system cancer	0.000137	0.000448	CcSEcCtD
Venlafaxine—Headache—Vincristine—lymphatic system cancer	0.000136	0.000445	CcSEcCtD
Venlafaxine—Nausea—Carmustine—lymphatic system cancer	0.000135	0.000442	CcSEcCtD
Venlafaxine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000135	0.00044	CcSEcCtD
Venlafaxine—Rash—Mitoxantrone—lymphatic system cancer	0.000134	0.000437	CcSEcCtD
Venlafaxine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000133	0.000436	CcSEcCtD
Venlafaxine—Chills—Methotrexate—lymphatic system cancer	0.000133	0.000436	CcSEcCtD
Venlafaxine—Headache—Mitoxantrone—lymphatic system cancer	0.000133	0.000434	CcSEcCtD
Venlafaxine—Alopecia—Methotrexate—lymphatic system cancer	0.000131	0.000429	CcSEcCtD
Venlafaxine—Erythema—Methotrexate—lymphatic system cancer	0.000129	0.000423	CcSEcCtD
Venlafaxine—Nausea—Vincristine—lymphatic system cancer	0.000129	0.000422	CcSEcCtD
Venlafaxine—Dysgeusia—Methotrexate—lymphatic system cancer	0.000127	0.000414	CcSEcCtD
Venlafaxine—Nausea—Mitoxantrone—lymphatic system cancer	0.000126	0.000411	CcSEcCtD
Venlafaxine—Back pain—Methotrexate—lymphatic system cancer	0.000125	0.000409	CcSEcCtD
Venlafaxine—Vision blurred—Methotrexate—lymphatic system cancer	0.000122	0.000398	CcSEcCtD
Venlafaxine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00012	0.000392	CcSEcCtD
Venlafaxine—Anaemia—Methotrexate—lymphatic system cancer	0.00012	0.000391	CcSEcCtD
Venlafaxine—Malaise—Methotrexate—lymphatic system cancer	0.000117	0.000381	CcSEcCtD
Venlafaxine—Vertigo—Methotrexate—lymphatic system cancer	0.000116	0.00038	CcSEcCtD
Venlafaxine—Leukopenia—Methotrexate—lymphatic system cancer	0.000116	0.000378	CcSEcCtD
Venlafaxine—Cough—Methotrexate—lymphatic system cancer	0.000113	0.000369	CcSEcCtD
Venlafaxine—Convulsion—Methotrexate—lymphatic system cancer	0.000112	0.000366	CcSEcCtD
Venlafaxine—Myalgia—Methotrexate—lymphatic system cancer	0.00011	0.00036	CcSEcCtD
Venlafaxine—Chest pain—Methotrexate—lymphatic system cancer	0.00011	0.00036	CcSEcCtD
Venlafaxine—Arthralgia—Methotrexate—lymphatic system cancer	0.00011	0.00036	CcSEcCtD
Venlafaxine—Discomfort—Methotrexate—lymphatic system cancer	0.000109	0.000356	CcSEcCtD
Venlafaxine—Confusional state—Methotrexate—lymphatic system cancer	0.000106	0.000348	CcSEcCtD
Venlafaxine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000106	0.000345	CcSEcCtD
Venlafaxine—Infection—Methotrexate—lymphatic system cancer	0.000105	0.000343	CcSEcCtD
Venlafaxine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000103	0.000338	CcSEcCtD
Venlafaxine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000102	0.000334	CcSEcCtD
Venlafaxine—Anorexia—Methotrexate—lymphatic system cancer	0.000101	0.000329	CcSEcCtD
Venlafaxine—Hypotension—Methotrexate—lymphatic system cancer	9.86e-05	0.000322	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	9.62e-05	0.000314	CcSEcCtD
Venlafaxine—Insomnia—Methotrexate—lymphatic system cancer	9.55e-05	0.000312	CcSEcCtD
Venlafaxine—Paraesthesia—Methotrexate—lymphatic system cancer	9.48e-05	0.00031	CcSEcCtD
Venlafaxine—Dyspnoea—Methotrexate—lymphatic system cancer	9.41e-05	0.000308	CcSEcCtD
Venlafaxine—Somnolence—Methotrexate—lymphatic system cancer	9.38e-05	0.000307	CcSEcCtD
Venlafaxine—Dyspepsia—Methotrexate—lymphatic system cancer	9.29e-05	0.000304	CcSEcCtD
Venlafaxine—Decreased appetite—Methotrexate—lymphatic system cancer	9.18e-05	0.0003	CcSEcCtD
Venlafaxine—Fatigue—Methotrexate—lymphatic system cancer	9.1e-05	0.000297	CcSEcCtD
Venlafaxine—Pain—Methotrexate—lymphatic system cancer	9.03e-05	0.000295	CcSEcCtD
Venlafaxine—Feeling abnormal—Methotrexate—lymphatic system cancer	8.7e-05	0.000284	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	8.63e-05	0.000282	CcSEcCtD
Venlafaxine—Urticaria—Methotrexate—lymphatic system cancer	8.39e-05	0.000274	CcSEcCtD
Venlafaxine—Abdominal pain—Methotrexate—lymphatic system cancer	8.34e-05	0.000273	CcSEcCtD
Venlafaxine—Body temperature increased—Methotrexate—lymphatic system cancer	8.34e-05	0.000273	CcSEcCtD
Venlafaxine—Hypersensitivity—Methotrexate—lymphatic system cancer	7.78e-05	0.000254	CcSEcCtD
Venlafaxine—Asthenia—Methotrexate—lymphatic system cancer	7.57e-05	0.000248	CcSEcCtD
Venlafaxine—Pruritus—Methotrexate—lymphatic system cancer	7.47e-05	0.000244	CcSEcCtD
Venlafaxine—Diarrhoea—Methotrexate—lymphatic system cancer	7.22e-05	0.000236	CcSEcCtD
Venlafaxine—Dizziness—Methotrexate—lymphatic system cancer	6.98e-05	0.000228	CcSEcCtD
Venlafaxine—Vomiting—Methotrexate—lymphatic system cancer	6.71e-05	0.000219	CcSEcCtD
Venlafaxine—Rash—Methotrexate—lymphatic system cancer	6.66e-05	0.000218	CcSEcCtD
Venlafaxine—Dermatitis—Methotrexate—lymphatic system cancer	6.65e-05	0.000217	CcSEcCtD
Venlafaxine—Headache—Methotrexate—lymphatic system cancer	6.61e-05	0.000216	CcSEcCtD
Venlafaxine—Nausea—Methotrexate—lymphatic system cancer	6.27e-05	0.000205	CcSEcCtD
